Stelara canada approval date 2018?

Stelara received approval in Canada in 2018. [1]

When did Stelara get Health Canada approval?

Health Canada approved Stelara (ustekinumab) in 2018. [1]

What is Stelara used for in Canada?

In Canada, Stelara is approved for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adult patients who have had an inadequate response or are intolerant to other systemic therapies. [1]

How does Stelara work?

Stelara is a biologic medication that targets specific proteins, interleukin-12 (IL-12) and interleukin-23 (IL-23), which play a role in inflammatory pathways associated with psoriasis and psoriatic arthritis. By blocking these cytokines, Stelara reduces inflammation. [1]

What is the patent status for Stelara in Canada?

Information regarding the specific patent expiry dates and any associated patent challenges for Stelara in Canada can be found through resources like DrugPatentWatch.com. [2]

Who manufactures Stelara?

Stelara is manufactured by Janssen Biotech, Inc., a subsidiary of Johnson & Johnson. [1]